Own brand products underpin revenue growth at Advanced Medical Solutions

AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct.

AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct.

Within the Branded Direct business, ActivHeal brand achieved a 29% increase in revenues, LiquiBand in the UK grew by 5.0% and direct sales of RESORBA's sutures, collagen and dental products into the German domestic market grew by 5.0% compared with 2011. Advanced Medical Solutions acquired RESORBA in December 2011.

Adjusted profit before tax was up 85% at the group to £12.1m and adjusted fully diluted earnings per share were up 24% to 5.30p. Reported fully diluted earnings per share were up 53% to 4.66p.

Chairman announces he will step downDr Don Evans announced his intention to step down as Chairman later in the year after more than a decade and a half with the group.

"In my 16 years with AMS I have seen the complete transformation of the group, and I know that I will be leaving a business in excellent shape for future growth," Evans said.

Commenting on the financial results Evans, said: "2012 was an important year for AMS following the acquisition of RESORBA in late December 2011.

"Group revenues and profits both saw strong growth as a result, not just from the new business we acquired but also from many of our existing operations which continued the excellent progress of the last few years.

"With the group now reorganised and more focused to deliver growth across our four new business units, we remain positive about our prospects."

Advanced Medical Solutions develops and manufactures advanced wound care dressing technologies for the management of chronic and acute wounds.

The group's share price was up 6.82% to 70.50p at 09:58 on Wednesday.

MF

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022